Åkervall JA, Michaelides RJAM, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , Cancer 1997 :79:380-389

Baron SH: Brain radiation necrosis following treatment of an esthesioneuroblastoma (olfactory neurozytoma), Laryngoscope 1979:89:214-223

Berger L, Luc R, Richard J: L ' esthesioneuroepitheliome olfactif, Bull Assoc Fr etude Cancer 1924:13:410-421

Berghaus A, Jovanovic S: Technique and indications of extended sublabial rhinotomy ("midfacial degloving"), Rhinology. 1991 :29:105-110

Biller HF, Lawson W, Lachdev V, Som P: Esthesioneuroblastoma: surgical treatment without radiation, Laryngoscope 1990:100:1199-1201

Bilsky MH, Kraus DH, Strong EW, Harrison LB, Gutin PH, Shah JP: Extended anterior craniofacial resection for intracranial extension of malignant tumors, Am. J. Surg. 1997: 174:565-568

Bissig H, Richter J, Desper R, Meier V, Schraml P, Schaffer AA, Sauter G, Mihatsch MJ, Moch H: Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization, Am J. Pathol. 1999:155:267-274

Bockmühl U: Molekularzytogenetische Charakterisierung von Plattenepithelkarzinomen des Kopf-Hals-Bereiches, Laryngol. Rhinol. Otol. 2000b:79:249-250

Bockmühl U, Ishwad CS, Ferrell RE, Gollin SM: Association of 8p23 deletions with poor survival in head and neck cancer, Otolaryngol. Head Neck Surg. 2001:124:451-455

Bockmühl U, Petersen I, Schwendel A, Dietel M: Genetisches Screening von Kopf-Hals-Karzinomen mittels der Komparativen Genomischen Hybridisierung (CGH). Laryngol. Rhinol. Otol., 1996b:75: 408-414

Bockmühl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, Petersen I : Patterns of chromosomal alterations in metastasizing and non metastasizing primary head and neck cancinomas, Cancer Res. 1997:57:5213-5216

Bockmühl U, Schlüns K, Küchler I, Petersen S, Petersen I: Genetic imbalances with impact on survival in head and neck cancer patients, Am J Pathol 2000a:157:369-375

Bockmühl U, Schlüns K, Schmidt S, Matthias S, Petersen I: Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma , Genes Chromosom. Cancer 2002 :33:29-35

[Seite 46↓]

Bockmühl U, Schwendel A, Dietel M, Petersen I: Distinct patterns of chromosomal alterations in high and low grade head and neck squamous cell carcinomas, Cancer Res. 1996a:56:5325-5329

Bockmühl U, Wolf G, Schmidt S, Schwendel A, Jahnke V, Dietel M, Petersen I: Genomic alterations associated with malignancy in head and neck cancer, Head Neck 1998:20:145-151

Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Böcker W, Störkel S: Synopse unbalancierter chromosomaler Aberrationen beim Neuroblastom durch komparative genomische Hybridisierung (CGH), Pathologe 1996:17:368-373

Broich G, Pagliari A, Ottaviani F: Esthesioneuroblastoma: a general rewiew of the cases published since the discovery of the tumor in 1924, Anticancer-Res. 1997:17(4A):2683-2706

Cantrell RW, Ghorayet BY, Fitz-Hugh GS: Esthesioneuroblastoma. Diagnosis and treatment , Ann. Otol. 1977:86:760-765

Chapman P, Carter RL, Clifford P: The diagnosis and surgical management of olfactory neuroblastoma: the role of craniofacial resection. J. Laryngol. Otol. 1981:95:785-799

Christiansen H, Lampert F: Tumorcytogenetik und Prognose beim Neuroblastom, Monatsschr. Kinderheilkd. 1989:137:666-671

Caron H: Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma, Med. Pediatr. Oncol. 1995:24:215-221

Davis RE, Weissler MC: Esthesioneuroblastoma and neck metastasis, Head Neck 1992:14:477-482

Devoe K, Weidner N: Immunohistochemistry of small round-cell tumors, Semin. Diagn. Pathol. 2000:17(3):216-224

Donald PJ: Frontobasal approach for trauma and tumor. Minim. Invasive Neurosurg. 1994:37:37-41

Doyle PJ, Payton HD: Combined surgical approach to esthesioneuroblastoma, Trans. Pa. Acad. Ophthalmol. Otolaryngol. 1971:75:526-531

Draf W, Berghaus A: Tumoren und Pseudotumoren („tumorähnliche Läsionen“) der frontalen Schädelbasis, ausgehend von der Nase, den Nasennebenhöhlen und dem Nasenrachenraum (einschliesslich der operativen Zugänge). Rhinochirurgisches Referat, Eur. Arch. Otorhinolaryngol. 1993:1(Suppl):105-18

Draf W, Samii M: Surgical treatment of malignant tumors of the paranasal sinuses with involvement of the base of the skull, Strahlenther. Onkol. 1989 :165:474-477

Draf W, Schauss F: External rhinoplasty: its role in aesthetic and functional surgery of the nose, Facial Plast. Surg. 1995:11:228-236

Dulguerov P, Calcaterra T: Esthesioneuroblastoma: the UCLA experience 1970-1990, Laryngoscope 1992:102: 843-849

[Seite 47↓]

du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T: Detection of complete and partial chromosome gain and losses by comparative genomic hybridization, Hum. Genet. 1993:90:590-610

Duesberg P, Rasnick D: Aneuploidy, the somatic mutation that makes cancer a species of its own, Cell Motil. Cytoskelet. 2000:47:81-107

Eden BV, Debo RF, Larner JM, Kelly MD, Levine PA, Stewart FM, Cantrell RW, Constable WC: Esthesioneuroblastoma: Long-term outcome and patterns of failure – the University of Virginia experience, Cancer 1994 :73:2556-2562

Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC: Esthesioneuroblastoma, Cancer 1979:44:1087-1094

Eriksen JG, Bastholt L, Krogdahl AS, Hansen O, Joergensen KE: Esthesioneuroblastoma: what is the optimal treatment? Acta Oncologica 2000:39:231-235

Feyerabend T: Die Stellung der Radiotherapie in der Behandlung des Ästhesioneuroblastoms, HNO 1990 :38:20-23

Girgert R, Treuner J, Schweizer P: Molekularbiologische Merkmale des Neuroblastoms als Grundlage eines Therapiekonzepts, Langenbecks Arch. Chir. Suppl II (Kongressbericht 1996) 1996:1053-1055

Gronwald J, Störkel S, Holtgreve-Grez H, Hdaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T: Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: Importance of 1q and 3p copy number changes in metastatic events, Cancer Res. 1997:57:481-487

Hanahan D, Weinberg RA: The hallmarks of cancer, Cell 2000:100:57-70

Hirose T, Scheithauer BW, Lopes M.BS, Gerber HA, Altermatt HJ, Harner SG, Vandenberg SR: Olfactory neuroblastoma, an immunohistochemical, ultrastructural, and flow cytometric study, Cancer 1995:76(1):4-19

Homize MJ, Elkon D: Olfactory esthesioneuroblastoma – variables predictive of tumor control and recurrence, Cancer 1980:46:2509-2513

Hyams VJ: Olfactory neuroblastoma (case 6). In: Batsakis JG, Hyams VJ, Moralea AR. Special Tumors of the Head and Neck. Chicago: American Society of Clinical Pathologists, 1983:24-29

Irish J, Freeman J, Gullane P, Gentili F, Brown D, Neligan P, O٬Sullivan B: Outcome and analysis of the surgical management of esthesioneuroblastoma, J. Otolaryngol. 1997:26:1-7

sola JI, Kallioniemi OP, Chu LW, Fuqua SAW, Hilsenbeck SG, Osborne CK, Waldman FM: Genetic aberration detected by Comparative Genomic Hybridization predict outcome in node-negative breast cancer, Am. J. Pathol. 1995 :147:905-911

[Seite 48↓]

Kadish S, Goodman M, Wang CC: Olfactory neuroblastoma: a clinical analysis of 17 cases, Cancer 1976:37: 1571-1576

Kairemo KJ, Jekunen AP, Kestila MS, Ramsay HA: Imaging of olfactory neuroblastoma – an analysis of 17 cases, Auris-Nasus-Larynx 1998:25:173-179

Kallioniemi A., Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparativ genomic hybridization. Proc. Natl. Acad. Sci. USA 1994b :91:2156-2160

Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992:258:818-821

Kallioniemi A., Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom. Cancer 1994a:10: 231-234

Kempf H-G, Becker G, Weber BP, Ruck P: Diagnostik und Therapie des Olfaktoriusneuroblastoms, HNO 1994:42:422-428

Kuukasjärvi T, Karhu R, tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer, Cancer res. 1997:57:1597-1604

Levin NA, Broszka P, Warnock ML, Gray JW, Christman MF: Identification of novel regions of altered DNA copy number in small cell lung tumors, Genes Chromosom. Cancer 1995:13:175-185

Levine PA, Debo RF, Meredith SD, Jane JA, Constable WC, Cantrell RW: Craniofacial resection at the University of Virginia (1976-1992): survival analysis. Head Neck 1994:16:574-577

Levine PA, Gallagher R, Canntrell RW: Esthesioneuroblastoma: reflections of a 21-years experience, Laryngoscope 1999:109:1539-1543

Lewis JS, Hutter R, Tollefsen HR, Foot F: Nasal tumors of olfactory origin, Arch. Otolaryngol. 1965:81:169-173

Li J, Yen C, Liaw D, Podsypania K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science 1997:275:1943-1947

Lund VJ, Milroy C: Olfactory neuroblastoma: clinical and pathological aspects, Rhinology 1993:31(1):1-6

Miyamoto RC, Gleich LL, Biddinger W, Gluckman JL: Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis, Laryngoscope 2000:110:1262-1265

[Seite 49↓]

Moch H, Presti, Jr JC, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM: Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma, Cancer Res. 1996:56:27-30

Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wigenbus KK, von Deimling A, Poustka A: DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors, Nature Genet. 1997: 17:32-39

Morita A, Ebersold MJ, Oslen KD, Foote R:L, Lewis JE, Quast LM: Esthesioneuroblastoma: Prognosis and Management, Neurosurgery 1993:32:706-715

Moure EI: Technique chirurgicale oto-rhino-laryngologique. Premier fascicule, L’oreille et ses anexes, Libraire Octave Dein, Paris , 1922

Obermann HA, Rice DH: Olfactory neuroblastomas: a clinicopathologic study, Cancer 1976:38:2494-2502

O٬Connor TA, McLean P, Juillard GJF, Parker RG: Olfactory neuroblastoma, Cancer 1989:63:2426-2428

Papadaki H, Kounelis S, Kapadia SB, Bakker A, Swalsky PA, Finkelstein SD: Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma, Am. J. Surg. Pathol. 1996:20 (6): 715-721

Parsons JT, Mendenhall WM, Mancuso AA, Cassisi NJ, Million RR : Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses, Int.J. Radiat. Oncol. Biol. Phys. 1988: 14: 11-22

Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T: Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung, Cancer Res. 1997:a :57: 2331-2335

Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel M, Ried T, Dietel M: Small cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p, Br. J. Cancer 1997b :75: 79-86

Petersen I, Schwendel A, Bockmühl U, Dietel M: Die Komparative Genomische Hybridisierung: Eine Screeningmethode in der genetischen Tumordiagnostik. Pathologe, 1996:17: 333-341

Petersen S, Wolf G, Bockmühl U, Gellert M, Dietel M, Petersen I : Allelic loss on chromosome 10q in human lung cancer: association with tumor progression and metastatic phenotype , Br. J. Cancer 1998 :77:270-276

Ranjan D, Hennessy RG: Esthesioneuroblastoma: cerebral and spinal metastases without direct cranial invasion, J. Neurooncol. 1986 :4: 71-74.

Raveh J, Laedrach K, Speiser M, Chen J, Vuillemin T, Seiler R, Ebeling U, Leibinger K: The subcranial approach for fronto-orbital and anteroposterior skull-base tumors. Arch. Otolaryngol. Head Neck Surg. 1993:119:385-93.

Reichel MB, Ohgaki H, Petersen I, Kleihues P: p53 mutations in primary human lung tumors and their metastases, Mol. Carcinog. 1993 :139-143

[Seite 50↓]

Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee D-L, Westra WH : Esthesioneuroblastoma: the Johns Hopkins experience, Head Neck 2000 :22: 550-558

Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schröck E, du Manoir S, Cremer T: Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization, Cancer Res. 1994 :54: 1801-1806

Roth K, Wolf G, Dietel M, Petersen I: Image analysis for Comparative genomic Hybridization based on a karyotyping program for Windows. Anal. Quant. Cytol. Histol. 1997:19:461-474

Sambrook J, Fritsch EF, Maniatis T: Molekular Cloning: A Laboratory Manual. 2. Auflage, Cold Spring Harbor Laboratory, New York, 1989

Samii M, Draf W: Surgery of the Skull Base. Heidelberg, Berlin, New York : Springer, 1989

Schmidt JL, Zarbo RJ, Clark JL: Olfactory neuroblastoma: Clinico-pathologic and immunohistochemical characterization of four representative cases, Laryngoscope 1990:100:1052-1058

Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nürnberg P, Vogel S, Jänisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T: Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses, Am. J. Pathol. 1994:144:1203-1218

Schuster V, Kreth HW: Molekularbiologische Aspekte des Neuroblastoms, Monatsschr. Kinderheilkd. 1987:135:672-676

Schwendel A, Langreck H, Reichel M, Schröck E, Ried T, Dietel M, Petersen I: Primary small cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations, Int. J. Cancer 1997:74:86-93

Simon JH, Zhen WN, McCulloch TM, Hoffman HT, Paulino AC, Mayr NA, Buatti JM: Esthesioneuroblastoma: the University of Iowa experience 1978-1998, Laryngoscope 2001:111:488-493

Smith RR, Klopp CT, Williams JM: Surgical treatment of cancer of the frontal sinus and adjacent areas, Cancer 1954:7: 991-994

Spaulding CA, Kranyak MS, Constable WC, Stewart FM: Esthesioneuroblastoma: a comparison of two treatment eras, Int. J. Radiat. Oncol. Biol. Phys. 1988:15:581-590

Speicher MR, du Manoir S, Schröck E, Holtgreve-Grez H, Schoell B, Lengauer C, Cremer T, Ried T: Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification, Hum. Mol. Genet. 1993 :2: 1907-1914

Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigan SV: Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , Nature Genet. 1997:15:356-362

[Seite 51↓]

Szymas J, Wolf G, Kowalczyk D, Nowak S, Petersen I : Olfactory neuroblastoma: Detection of genomic imbalances by comparative genomic hybridization, Acta Neurochir. (Wien) 1997:139:839-844

van Dyke D, Worsham MJ, Benninger MS, Krause CJ, Baker SR, Wolf GT, Drumheller T, Tilley BC, Carey TE: Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region, Genes Chromosom. Cancer 1994 :9: 192-206

Verma RS, Babu A: Human Chromosomes: Principles and Techniques. 2. Auflage, McGrraw-Hill, New York, 1994

Vollrath M: Chemically induced esthesioneuroepithelioma: a cytogenetic, cell culture and biochemical investigation with implications for tumor histogenesis , Arch. Otorhinolaryngol. 1989:246:71-78

Walch C, Stammberger H, Unger F, Angerhuber W: Ein neues Therapiekonzept bei Ästhesioneuroblastom, Laryngol. Rhinol. Otol. 2000:79:743-748

Weber R, Keerl R, Draf W, Schick B, Mosler P, Saha A: Management of dural lesions occurring during endonasal sinus surgery. Arch. Otolaryngol. Head Neck Surg. 1996:122:732-736.

Weber R, Sabel M, Reifenberger J, Sommer C, Oberstraß J, Reifenberger G, Kiessling M, Cremer T: Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization, Oncogene 1996:12:983-994

Wick MR, Stamley SJ: Immunohistochemical diagnosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and anti-synaptophysin, Arch. Pathol. Lab. Med. 1988:112:616-620

Wright K, Manos MM: PCR Protocols: A guide to methods and amplications. Academic Press Inc., 1990:153-158

Zappia JJ, Caroll WR, Wolf GT, Thornton AT, Ho L, Krause CJ: Olfactory neuroblastoma: the results of modern treatment approaches at the University of Michigan, Head Neck 1993:15:190-196

Zumegen C, Michel O: Problematik der Klassifikation und Prognose des Aesthsioneuroblastoms anhand von sieben therapierten Fällen, Laryngol. Rhinol. Otol. 2000:79:736-742

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: